Australia | Oct 17 2023
This story features MAGELLAN GLOBAL FUND, and other companies. For more info SHARE ANALYSIS: MGF
Download related file: IIR-Monthly-LMI-Update_-4-October-2023
A Listed Investment Company (LIC) is a listed investment vehicle that offers investors access to a diversified portfolio of shares in other companies also listed on the stock market. Also known as Listed Investment Trusts or Listed Managed Investments.
For comprehensive comparative data tables for LICs please see attached (login required).
LMI Market News
Pressure Mounts on MGF
The pressure is mounting on Magellan Global Fund ((MGF)) to close the discount, with an article in the Australian Financial Review on 19 September 2023 suggesting that Nick Bolten is seeking to garner support for a unitholder meeting to put forward a resolution that requires the redemption of units at NAV.
We note that Nick Bolten reportedly holds a large number of MGF options, which are set to expire on 1 March 2024. So let’s talk about the options…..
The options were issued in March 2021, as part of a Bonus Options issue and through the Partnership Offer. A total of 1,068.66 million options were issued with the options due to expire on 1 March 2024. The options have an exercise price set at a -7.5% discount to the prevailing NAV at the time of exercise. The options can be exercised at any time up until the expiry date at which time any unexercised options will lapse.
To be in-the-money, the market price of MGF needs to be trading at a discount of less than -7.5% to NAV. The Fund has traded at a discount in excess of -7.5% for the majority of the term of the options which has seen the options be out-of-the-money for a large portion of the time on issue and has resulted in very few options being exercised.
So what would be the potential outcome if there was a successful resolution for the Fund to redeem units at NAV? It would be expected that the market price of MGF would re-rate towards the NAV providing an opportunity for the options to be trading in-the-money and the potential for a capital gain to be made from the difference between the option price and the prevailing NAV.
Normally the exercise of options would be dilutive to unitholders given the discount at which the options are exercised, however the Manager will bear the economic cost of the discount so unitholders of the Fund do not experience dilution from the exercise of options. This liability is something that the Manager will be very cognisant of and will no doubt impact the decision making of the Manager and the Responsible Entity, both of which fall under the Magellan Asset Management umbrella.
Regal Resources Royalties Fund Seeks to Raise Capital for Transactions
During the month, the Regal Resources Royalties Fund announced it was seeking to raise capital to fund an investment with a Canadian royalty company. The transaction will comprise an acquisition of a royalty over one of Canada’s largest gold mines and an equity investment in the Canadian royalty company, which will provide exposure to an existing royalty portfolio.
The Fund also highlighted a pipeline of investment opportunities for the Fund. Regal Investment Fund ((RF1)) had a 19% exposure to the Regal Resources Royalties Fund as at 31 August 2023. IIR views the diversification of the portfolio as a positive for the Regal Resources Royalties Fund as it diversifies the portfolio from both an investment and commodity perspective. We view this as beneficial to RF1 investors who have a significant exposure to the fund.
RF1 can have an allocation of up to 25% in the strategy, as such there is potential for RF1 to participate in the capital raising, however this will be at the discretion of the Investment Committee for RF1.
BKI Completes Acquisition of Unlisted Investment Company
During the month, BKI Investment Company Limited ((BKI)) announced it had completed the acquisition of an unlisted investment company with net assets of ~$15.7 million. Consideration for the acquisition was 8.88 million new BKI shares which were issued at a price of $1.76 per share, totalling $15.6m million. The Company has 802.8 million shares on issue post the issue of the new shares for the acquisition.
CAM Announces Share Purchase Plan
On 15 September 2023, Clime Capital Limited ((CAM)) announced a Share Purchase Plan (SPP) offering eligible shareholders the opportunity to acquire up to $30,000 of CAM shares at a fixed price of $0.81 per share. The issue price represented a -1.2% discount to the closing share price on the day prior to the announcement and a -3.6% discount to the most recently reported pre-tax NTA prior to the announcement.
The offer opened on 18 September 2023 and closed on 29 September 2023. The Company raised approximately $4.5 million with 5.6 million new shares issued under the SPP.
The Company stated the primary purpose of the discount is to grow the Company’s assets to gain additional access to market opportunities. The Company further stated that the increased size of the Company is expected to reduce the fixed expense ratio to benefit all shareholders. In addition to the stated expected benefits to shareholders, the Manager will also benefit from increased fees from the expanded assets under management.
Alex Shevelev Promoted to Portfolio Manager for Forager Australian Shares Fund
On 15 September 2023, Forager Australian Shares Fund ((FOR)) announced Alex Shevelev has been promoted to Portfolio Manager of the Fund. Alex will co-manage the portfolio alongside the founder of Forager, Steve Johnson.
Alex joined Forager in 2017 and his promotion was a result of his strong contribution to fund performance and portfolio construction. The two Portfolio Manager’s will each have direct responsibility for a portion of the portfolio.
FOR’s portfolio has rebounded from the substantial declines experienced in 1H’CY22. The total cumulative NAV declined -35.3% in 1H’CY22. Since bottoming out in June 2022, the NAV has increased 23.9% to 31 August 2023.
Independent Investment Research, “IIR”, is an independent investment research house based in Australia and the United States. IIR specialises in the analysis of high quality commissioned research for Brokers, Family Offices and Fund Managers. IIR distributes its research in Asia, United States and the Americas. IIR does not participate in any corporate or capital raising activity and therefore it does not have any inherent bias that may result from research that is linked to any corporate/ capital raising activity.
IIR was established in 2004 under Aegis Equities Research Group of companies to provide investment research to a select group of retail and wholesale clients. Since March 2010, IIR (the Aegis Equities business was sold to Morningstar) has operated independently from Aegis by former Aegis senior executives/shareholders to provide clients with unparalleled research that covers listed and unlisted managed investments, listed companies, structured products, and IPOs. IIR takes great pride in the quality and independence of our analysis, underpinned by high caliber staff and a transparent, proven and rigorous research methodology.
INDEPENDENCE OF RESEARCH ANALYSTS
Research analysts are not directly supervised by personnel from other areas of the Firm whose interests or functions may conflict with those of the research analysts. The evaluation and appraisal of research analysts for purposes of career advancement, remuneration and promotion is structured so that non-research personnel do not exert inappropriate influence over analysts.
Supervision and reporting lines: Analysts who publish research reports are supervised by, and report to, Research Management. Research analysts do not report to, and are not supervised by, any sales personnel nor do they have dealings with Sales personnel
Evaluation and remuneration: The remuneration of research analysts is determined on the basis of a number of factors, including quality, accuracy and value of research, productivity, experience, individual reputation, and evaluations by investor clients.
INDEPENDENCE – ACTIVITIES OF ANALYSTS
IIR restricts research analysts from performing roles that could prejudice, or appear to prejudice, the independence of their research.
Pitches: Research analysts are not permitted to participate in sales pitches for corporate mandates on behalf of a Broker and are not permitted to prepare or review materials for those pitches. Pitch materials by investor clients may not contain the promise of research coverage by IIR.
No promotion of issuers’ transactions: Research analysts may not be involved in promotional or marketing activities of an issuer of a relevant investment that would reasonably be construed as representing the issuer. For this reason, analysts are not permitted to attend “road show” presentations by issuers that are corporate clients of the Firm relating to offerings of securities or any other investment banking transaction from that our clients may undertake from time to time. Analysts may, however, observe road shows remotely, without asking questions, by video link or telephone in order to help ensure that they have access to the same information as their investor clients.
Widely-attended conferences: Analysts are permitted to attend and speak at widely-attended conferences at which our firm has been invited to present our views. These widely-attended conferences may include investor presentations by corporate clients of the Firm.
Other permitted activities: Analysts may be consulted by Firm sales personnel on matters such as market and industry trends, conditions and developments and the structuring, pricing and expected market reception of securities offerings or other market operations. Analysts may also carry out preliminary due diligence and vetting of issuers that may be prospective research clients of ours.
INDUCEMENTS AND INAPPROPRIATE INFLUENCES
IIR prohibits research analysts from soliciting or receiving any inducement in respect of their publication of research and restricts certain communications between research analysts and personnel from other business areas within the Firm including management, which might be perceived to result in inappropriate influence on analysts’ views.
Remuneration and other benefits: IIR procedures prohibit analysts from accepting any remuneration or other benefit from an issuer or any other party in respect of the publication of research and from offering or accepting any inducement (including the selective disclosure by an issuer of material information not generally available) for the publication of favourable research. These restrictions do not preclude the acceptance of reasonable hospitality in accordance with the Firm’s general policies on entertainment, gifts and corporate hospitality.
This publication has been prepared by Independent Investment Research (Aust) Pty Limited trading as Independent Investment Research (“IIR”) (ABN 11 152 172 079), an corporate authorised representative of Australian Financial Services Licensee (AFSL no. 410381. IIR has been commissioned to prepare this independent research report (the “Report”) and will receive fees for its preparation. Each company specified in the Report (the “Participants”) has provided IIR with information about its current activities. While the information contained in this publication has been prepared with all reasonable care from sources that IIR believes are reliable, no responsibility or liability is accepted by IIR for any errors, omissions or misstatements however caused. In the event that updated or additional information is issued by the “Participants”, subsequent to this publication, IIR is under no obligation to provide further research unless commissioned to do so. Any opinions, forecasts or recommendations reflects the judgment and assumptions of IIR as at the date of publication and may change without notice. IIR and each Participant in the Report, their officers, agents and employees exclude all liability whatsoever, in negligence or otherwise, for any loss or damage relating to this document to the full extent permitted by law. This publication is not and should not be construed as, an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. Any opinion contained in the Report is unsolicited general information only. Neither IIR nor the Participants are aware that any recipient intends to rely on this Report or of the manner in which a recipient intends to use it. In preparing our information, it is not possible to take into consideration the investment objectives, financial situation or particular needs of any individual recipient. Investors should obtain individual financial advice from their investment advisor to determine whether opinions or recommendations (if any) contained in this publication are appropriate to their investment objectives, financial situation or particular needs before acting on such opinions or recommendations. This report is intended for the residents of Australia. It is not intended for any person(s) who is resident of any other country. This document does not constitute an offer of services in jurisdictions where IIR or its affiliates do not have the necessary licenses. IIR and/or the Participant, their officers, employees or its related bodies corporate may, from time to time hold positions in any securities included in this Report and may buy or sell such securities or engage in other transactions involving such securities. IIR and the Participant, their directors and associates declare that from time to time they may hold interests in and/or earn brokerage, fees or other benefits from the securities mentioned in this publication.
IIR, its officers, employees and its related bodies corporate have not and will not receive, whether directly or indirectly, any commission, fee, benefit or advantage, whether pecuniary or otherwise in connection with making any statements and/or recommendation (if any), contained in this Report. IIR discloses that from time to time it or its officers, employees and related bodies corporate may have an interest in the securities, directly or indirectly, which are the subject of these statements and/or recommendations (if any) and may buy or sell securities in the companies mentioned in this publication; may affect transactions which may not be consistent with the statements and/or recommendations (if any) in this publication; may have directorships in the companies mentioned in this publication; and/or may perform paid services for the companies that are the subject of such statements and/or recommendations (if any). However, under no circumstances has IIR been influenced, either directly or indirectly, in making any statements and/or recommendations (if any) contained in this Report. The information contained in this publication must be read in conjunction with the Legal Notice that can be located at http://www.independentresearch.com.au/Public/Disclaimer.aspx.
Content included in this article is not by association the view of FNArena (see our disclaimer).
Find out why FNArena subscribers like the service so much: "Your Feedback (Thank You)" – Warning this story contains unashamedly positive feedback on the service provided.
FNArena is proud about its track record and past achievements: Ten Years On
For more info SHARE ANALYSIS: BKI - BKI INVESTMENT CO. LIMITED
For more info SHARE ANALYSIS: CAM - CLIME CAPITAL LIMITED
For more info SHARE ANALYSIS: FOR - FORAGER AUSTRALIAN SHARES FUND
For more info SHARE ANALYSIS: MGF - MAGELLAN GLOBAL FUND
For more info SHARE ANALYSIS: RF1 - REGAL INVESTMENT FUND